Publication:
Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain.

Simple item page
dc.contributor.authorRodriguez Del Rio, Pablo
dc.contributor.authorCaimmi, Davide
dc.contributor.authorRico, Pilar
dc.contributor.authorVidal, Carmen
dc.contributor.authorCarmen, Moreno
dc.contributor.authorPintoiu, Ileana M
dc.contributor.authorBeitia Mazuecos, Jose M
dc.contributor.authorGonzalez de Olano, David
dc.contributor.authorCuesta Alvaro, Pedro
dc.contributor.authorDemoly, Pascal
dc.contributor.authorCalderon, Moises A
dc.date.accessioned2023-05-03T13:28:37Z
dc.date.available2023-05-03T13:28:37Z
dc.date.issued2021-11-04
dc.description.abstractThe COVID-19 pandemic represents a global health crisis and a challenge at all societal, economic and health levels. With the first cases having been reported in most of the European countries in January 2020,1 it was not until March that the pandemic hit the territory and lead to an unprecedent hard lock-down in most countries.
dc.description.versionSi
dc.identifier.citationRodriguez Del Rio P, Caimmi D, Rico P, Vidal C, Carmen M, Pintoiu IM, et al. Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain. Clin Exp Allergy. 2022 Jan;52(1):167-170
dc.identifier.doi10.1111/cea.14043
dc.identifier.essn1365-2222
dc.identifier.pmcPMC8653094
dc.identifier.pmid34747540
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653094/pdf
dc.identifier.unpaywallURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653094
dc.identifier.urihttp://hdl.handle.net/10668/19923
dc.issue.number1
dc.journal.titleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
dc.journal.titleabbreviationClin Exp Allergy
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number167-170
dc.publisherWiley
dc.pubmedtypeLetter
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/10.1111/cea.14043
dc.rights.accessRightsopen access
dc.subjectAnti-allergic agents
dc.subjectCOVID-19
dc.subjectDesensitization, immunologic
dc.subjectFrance
dc.subject.decsCuarentena
dc.subject.decsEspaña
dc.subject.decsHipersensibilidad
dc.subject.decsPautas de la práctica en medicina
dc.subject.meshHumans
dc.subject.meshHypersensitivity
dc.subject.meshPractice patterns, physicians'
dc.subject.meshQuarantine
dc.subject.meshSARS-CoV-2
dc.subject.meshSpain
dc.titleReal-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number52
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC8653094.pdf
Size:
371.33 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Reina Sofía
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía